China venture capital

Cheaper entry valuations and ample exit options are reigniting Chinese VC activity

The Covid-19 pandemic is pushing renewed interest into healthcare sectors, where VC’s are looking for investments that not only survive but thrive under these unpredictable conditions.

Despite a pickup of activity in March, venture capital (VC) financing fell by more than half to $3.8 billion during the first quarter of 2020 compared to the same period last year, according to the Asian Venture Capital Journal. With investors unable to travel or channel check companies, most activity was understandably put on hold.

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media